Cosela® (Chinese brand name: Kesaila®) is the commercial brand name of Trilaciclib Hydrochloride for Injection, a short-acting reversible CDK4/6 inhibitor jointly developed by G1 Therapeutics and Simcere Pharmaceutical. It blocks normal bone marrow hematopoietic progenitor cells at the G1 phase…
Velphoro® (Chinese brand name: Weifurui®) is the commercial brand name of Sucroferric Oxyhydroxide Chewable Tablets, a non-calcium oral phosphate binder developed by Fresenius Medical Care. It combines with dietary phosphate within the gastrointestinal tract to form insoluble phosphate complexes excreted…
Fosrenol® (Chinese brand name: Fusilinuo®) is the commercial brand name of Lanthanum Carbonate Chewable Tablets, a non-calcium, non-aluminum oral phosphate binder developed by Shire Pharmaceuticals. It binds phosphate from food in the gastrointestinal tract to form insoluble lanthanum phosphate compounds…
Renvela® (Chinese brand name: Nuoweile®) is the commercial brand name of Sevelamer Carbonate Tablets, a non-calcium, non-aluminum oral phosphate binder developed by Sanofi. It binds dietary phosphate within the intestinal tract to form insoluble complexes excreted via feces, lowering serum…
Lokelma® (Chinese brand name: Libeizhuo®) is the commercial brand name of Sodium Zirconium Cyclosilicate Powder, an inorganic zirconium silicate selective potassium binder developed by AstraZeneca. It works by selectively capturing potassium ions in the gastrointestinal tract and excreting bound potassium…
Ferriprox® (Chinese brand name: Aobeianke®) is the commercial brand name of Deferiprone Tablets, an oral bidentate iron chelator developed by ApoPharma (Apotex Group). It binds excessive labile iron in the body to form water-soluble iron complexes that are excreted mainly…
Exjade® (Chinese brand name: Enruige®) is the commercial brand name of Deferasirox Dispersible Tablets, an oral once-daily iron chelating agent developed by Novartis. It is an orally active tridentate iron chelator that selectively binds excess non-transferrin bound iron and labile…
Keshuting® is the commercial brand name of Sugammadex Sodium Injection, a selective relaxant binding agent developed by Hunan Kelun Pharmaceutical. It is a cyclodextrin derivative that specifically encapsulates steroidal neuromuscular blocking agents (rocuronium bromide and vecuronium bromide) to rapidly reverse…
Vabysmo® (Chinese brand name: Luoshijia®) is the commercial brand name of Faricimab Injection, a humanized bispecific monoclonal antibody developed by Roche. It simultaneously targets VEGF-A and Angiopoietin-2 (Ang-2). Via intravitreal injection, it blocks pathological retinal angiogenesis, vascular leakage and inflammatory…
Beovu® is the commercial brand name of Brolucizumab Injection, a high-concentration single-chain variable fragment anti-VEGF monoclonal antibody developed by Novartis. It binds vascular endothelial growth factor A (VEGF-A) potently to block pathological retinal neovascularization and vascular leakage via intravitreal administration,…